INVO Fertility, Inc. (IVF)
Nasdaq: IVF · Surgical & Medical Instruments & Apparatus · Sarasota, FL · filing with the SEC since 2007
Who owns INVO Fertility, Inc.
As filed with the SECHolders of 5% or more
2
Alumni Capital LP holds 9.99% of Common Stock, as its SCHEDULE 13G filed Aug 7, 2026 says.
Directors and officers
7
report now, of 14 people on the record since 2017. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Alumni Capital LP
SCHEDULE 13G · filed Aug 7, 2026 · Common Stock
Greenblock Capital, LLC
SCHEDULE 13G · filed Oct 28, 2025 · Common Stock
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 9.99% in May 15, 2026
Mitchell P. Kopin
SCHEDULE 13G/A · filed May 9, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%, from 6.9% in Jan 16, 2025
Glenbrook Capital Management
SCHEDULE 13G/A · filed Oct 9, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 8.33% in Apr 1, 2026
Five Narrow Lane LP
SCHEDULE 13G/A · filed Jan 21, 2026 · COMMON STOCK, $0.001 PAR VALUE PER SHARE · reported falling below 5%, from 9.99% in Jan 15, 2025
What IVF reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Alabama JV
An entity · legal entity · owns, named in the 10-K filed Jun 2, 2026
Cedar
An entity · legal entity · owns, named in the 10-K filed Jun 2, 2026
Georgia JV
An entity · consolidated entity · owns, named in the 10-K filed Jun 2, 2026
NAYA Therapeutics
A company bought · acquisition · May 2025 · owns, named in the 10-K filed Jun 2, 2026
Five Narrow Lane LP
A company bought · acquisition · Sep 2024 · owns, named in the 10-K filed Jun 2, 2026
Legacy Naya Merger
A company bought · acquisition · owns, named in the 10-K filed Jun 2, 2026
NAYA Therapeutics Inc
A company bought · acquisition · owns, named in the 10-K filed Jun 2, 2026
5 subsidiaries in 1 country, from the list filed with the 10-K filed Jun 2, 2026.
Insider tradesForm 4
1sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Szot Matthew K | director | 1 | $0 | 0 | 0 | $0 |